GENE ONLINE|News &
Opinion
Blog

2022-05-27| Special

Cell and Gene Therapy Landscape in Japan is Moving Beyond Oncology

by Sahana Shankar
Share To
photo credit to ASCGT

At the 25th annual meeting of the American Society for Cell and Gene Therapy, medical researchers from Japan showcased their expertise in developing gene therapy in a session titled ‘Cutting edge cell and gene therapy research in Japan’. Looking beyond oncology and genetic diseases, Japan’s biomedical community is working on developing new therapies, improving gene therapy efficiency and targeting specific tissues. The session showcased examples of the latest  developments in cell and gene therapy research in Japan. 

 

A roadmap to gene therapy for cardiovascular diseases

 

Dr. Yoshikazu Yonemitsu from Kyushu University reviewed the evolution of RNA therapy for cardiaovascular diseases and the importance of large scale, double-blinded and randomized clinical trials to eliminate biases and errors for evaluating the efficacy of cell therapy. While most gene therapy candidates focus on oncology and genetic diseases, clinical success for cardiovascular diseases has been limited.  

It's free! Log in now to read

LATEST
Should People Looking to Lose Weight Skip Sugar Substitutes?
2023-05-30
Advancing Next-Generation Cancer Metabolic Therapy by Targeting Critical Amino Acid Metabolic Pathways: An Interview with Brian A. Van Tine, MD, PhD
2023-05-26
Rona Therapeutics, Keymed Biosciences Team Up To Develop siRNA Drugs For Kidney Disease
2023-05-25
CDC Calls an End to J&J’s COVID-19 Vaccine in the U.S.
2023-05-25
A Close Look at the Evolution of ESG in Biopharma
2023-05-22
Scientists Identified Potential New Drugs to Combat Blindness
2023-05-21
FDA Approves Astellas’ Non-hormonal Menopause Treatment After Extended Review
2023-05-19
EVENT
2023-05-16
The 2nd International Healthcare Week
Hong Kong , China
2023-06-02
2023 ASCO annual meeting
Chicago, USA
2023-07-26
BIO Asia-Taiwan 2023
Taipei, Taiwan
2023-09-06
2023 Bio Asia Pacific
Bangkok, Thailand
Scroll to Top